BEACOPPescalated versus ABVD in advanced Hodgkin's lymphoma

被引：3
作者：
Andre, Marc [1 ,2 ]
Bosly, Andre [1 ,2 ]
机构：
[1] CHU UCL Mont Godinne Dinant, Yvoir, Belgium
[2] Lymphoma Study Assoc, Lyon, France
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 10期
关键词：
CHEMOTHERAPY; BEACOPP;
D O I：
10.1016/S1470-2045(13)70382-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：911 / 912
页数：3
相关论文
共 9 条
[1]   Long-term cause-specific mortality of patients treated for Hodgkin's disease [J].
Aleman, BMP ;
van den Belt-Dusebout, AW ;
Klokman, WJ ;
van't Veer, MB ;
Bartelink, H ;
van Leeuwen, FE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3431-3439
[2]   International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers [J].
Biggi, Alberto ;
Gallamini, Andrea ;
Chauvie, Stephane ;
Hutchings, Martin ;
Kostakoglu, Lale ;
Gregianin, Michele ;
Meignan, Michel ;
Malkowski, Bogdan ;
Hofman, Michael S. ;
Barrington, Sally F. .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) :683-690
[3]   CHEMOTHERAPY OF ADVANCED HODGKINS-DISEASE WITH MOPP, ABVD, OR MOPP ALTERNATING WITH ABVD [J].
CANELLOS, GP ;
ANDERSON, JR ;
PROPERT, KJ ;
NISSEN, N ;
COOPER, MR ;
HENDERSON, ES ;
GREEN, MR ;
GOTTLIEB, A ;
PETERSON, BA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1478-1484
[4]   Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease [J].
Diehl, V ;
Franklin, J ;
Pfreundschuh, M ;
Lathan, B ;
Paulus, U ;
Hasenclever, D ;
Tesch, H ;
Herrmann, R ;
Dörken, B ;
Müller-Hermelink, H ;
Dühmke, E ;
Loeffler, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) :2386-2395
[5]   ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial [J].
Federico, Massimo ;
Luminari, Stefano ;
Iannitto, Emilio ;
Polimeno, Giuseppe ;
Marcheselli, Luigi ;
Montanini, Antonella ;
La Sala, Antonio ;
Merli, Francesco ;
Stelitano, Caterina ;
Pozzi, Samantha ;
Scalone, Renato ;
Di Renzo, Nicola ;
Musto, Pellegrino ;
Baldini, Luca ;
Cervetti, Giulia ;
Angrilli, Francesco ;
Mazza, Patrizio ;
Brugiatelli, Maura ;
Gobbi, Paolo G. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) :805-811
[6]   ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma [J].
Meyer, Ralph M. ;
Gospodarowicz, Mary K. ;
Connors, Joseph M. ;
Pearcey, Robert G. ;
Wells, Woodrow A. ;
Winter, Jane N. ;
Horning, Sandra J. ;
Dar, A. Rashid ;
Shustik, Chaim ;
Stewart, Douglas A. ;
Crump, Michael ;
Djurfeldt, Marina S. ;
Chen, Bingshu E. ;
Shepherd, Lois E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (05) :399-408
[7]   Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis [J].
Skoetz, Nicole ;
Trelle, Sven ;
Rancea, Michaela ;
Haverkamp, Heinz ;
Diehl, Volker ;
Engert, Andreas ;
Borchmann, Peter .
LANCET ONCOLOGY, 2013, 14 (10) :943-952
[8]   ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned [J].
Viviani, Simonetta ;
Zinzani, Pier Luigi ;
Rambaldi, Alessandro ;
Brusamolino, Ercole ;
Levis, Alessandro ;
Bonfante, Valeria ;
Vitolo, Umberto ;
Pulsoni, Alessandro ;
Liberati, Anna Marina ;
Specchia, Giorgina ;
Valagussa, Pinuccia ;
Rossi, Andrea ;
Zaja, Francesco ;
Pogliani, Enrico M. ;
Pregno, Patrizia ;
Gotti, Manuel ;
Gallamini, Andrea ;
Scalabrini, Delia Rota ;
Bonadonna, Gianni ;
Gianni, Alessandro M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (03) :203-212
[9]   Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas. [J].
Younes, Anas ;
Bartlett, Nancy L. ;
Leonard, John P. ;
Kennedy, Dana A. ;
Lynch, Carmel M. ;
Sievers, Eric L. ;
Forero-Torres, Andres .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) :1812-1821
1